Hello dear colleagues, Research status at Vanderbilt University Medical Center's aligns with OHSU's level 1, and we are actively planning for next levels as the situation evolves. Information for VUMC research labs and cores is updated here: https://www.vumc.org/oor/contingency-planning-vumc-research-labs-and-cores VUMC-wide information is updated here: https://www.vumc.org/coronavirus/information-vumc-employees-and-patients I wish you all the best in the months to come - stay well. Susan Susan Meyn Senior Director | Office of Research | Vanderbilt University Medical Center Twitter: @VUMCResearch | <email obscured> | 615.322.0470 On 3/18/20, 8:15 PM, "Core Administrators Network Forum on behalf of Gilpin, Christopher J" <email obscured> on behalf of <email obscured>> wrote: Purdue is at level 1. Chris He/Him/His Christopher J. Gilpin Ph.D. Director, Life Science Microscopy Facility Purdue University Whistler Hall of Agriculture Research, Room S052 170 S. University St West Lafayette, IN 47907 765-494-7750 <email obscured> <email obscured> reaches everyone in the facility -----Original Message----- From: Core Administrators Network Forum <email obscured>> On Behalf Of chitty Sent: Wednesday, March 18, 2020 12:29 PM To: <email obscured> Subject: [core administrators network forum] OHSU Guidelines for COVID19 research activities Just to let folks know how OHSU is handling operations, in case you want to compare: With the ongoing COVID-19 pandemic, we are defining five levels of responsiveness that laboratories at OHSU will be required to adhere to. Our goals are to keep our research community safe and healthy, support research on the SARS-CoV-2 virus and its accompanying COVID-19 disease, practice the necessary social distancing required to minimize coronavirus spread in the community, and most importantly, to reduce the impact of research operations on the functioning of the healthcare mission. As of today (3/17/20), we are at Level 1. When modified operations begin on Monday, we will be at Level 2. I fully expect OHSU to move to Level 3 immediately, and you should be prepared for us to move to Level 4 as early as the middle or end of next week. Note that multiple triggers may catalyze the transition to Level 3 or Level 4, for example a significant depletion of DCM staff (e.g., from child-care responsibilities or illness). These actions are consistent with what our colleagues are doing at other institutions, especially those affiliated with hospitals. Note that this communication is focused on laboratory research, not clinical research. Clinical research has been addressed in this document. If you have not done so, you should plan for how you will curtail lab operations and eventually shut them down. See the two sample plans: a blank one courtesy of UCSF and the plan created by my lab. This is a living policy that will evolve as conditions change. Stay safe. Levels of Research Operations Level 0 Normal operations Level 1 Teleworking encouraged Social distancing required Level 2 Lab research shutdown plan reviewed and approved by chair or director by Thursday, March 19 (we will provide a fillable form within a few days, but please do not wait for that) No new experiments Essential experiments allowed—those that, if discontinued, would generate significant financial or data loss No more than 3 lab members designated as critical staff; rotations allowed Students should not be working in the lab (this policy is under reconsideration) All research buildings will be locked Maintenance of key resources—animals, cell lines, liquid N2, etc. Separate policies for nonhuman primate research Separate policies for COVID-19 research Level 3 ALL experiments stopped Revised lab research shutdown plan reviewed and approved by chair or director within 24 hours of announcement of transition to Level 3 (we will provide a fillable form within a few days, but please do not wait for that) Research action plan filed with OHSU Research & Innovation within 24 hours of announcement of transition to Level 3 (we will provide a link for filing in the next 48 hours) All research buildings will be locked No more than 2 lab members designated as critical staff; rotations allowed ONLY in cases of emergency with department approval and notification of OHSU Research & Innovation One person per lab allowed on campus at any given time Lab staff must freely volunteer to come to OHSU—no coercion allowed Building access may be restricted, so expect that only designated critical staff will be allowed in Key resource maintenance allowed—animals, cell lines, liquid N2, etc. Mandatory reduction of rodent colony size (see message from Kim Saunders on 3/16/20; further guidance will be coming) For those labs with large rodent colonies, depletion of DCM staff may require those labs to assist in animal care Separate policies for nonhuman primate research Separate policies for COVID-19 research ALL exceptions reviewed and approved by OHSU Research & Innovation Level 4 NO LAB STAFF OR PI BUILDING ACCESS AT ALL Revised lab research shutdown plan reviewed and approved by chair or director within 24 hours of announcement of transition to Level 4 (we will provide a fillable form within a few days, but please do not wait for that) Liquid N2 maintenance ONLY by Research Stores—cannot be guaranteed, however (further messaging coming 3/18/20) Animal management ONLY by Department of Comparative Medicine (DCM) Exceptions only allowed for irreplaceable animals not managed by DCM (e.g., transgenic zebrafish, Drosophila lines) For rodents, Gold Star-labeled cages will be prioritized but care cannot be guaranteed (further messaging coming 3/18/20) Mandatory reduction of rodent colony size Separate policies for nonhuman primate research Separate policies for COVID-19 research ALL exceptions reviewed and approved by OHSU Research & Innovation (review process will be forthcoming) Animal exceptions reviewed and approved by DCM (review process will be forthcoming) ―― View topic https://nam05.safelinks.protection.outlook.com/?url=http%3A%2F%2Flist.abrf.org%2Fr%2Ftopic%2F2dOOk0vLopxElAh4HibnE0&data=02%7C01%7Cs.meyn%40vumc.org%7C949fc3ae02e3426370dd08d7cba31260%7Cef57503014244ed8b83c12c533d879ab%7C0%7C0%7C637201773558937916&sdata=V0h6nEexlDqOnA4ayOS9uvdAT2ET7Gd5cWf%2FNuc0kpk%3D&reserved=0 Leave group <email obscured>?Subject=Unsubscribe ―― View topic https://nam05.safelinks.protection.outlook.com/?url=http%3A%2F%2Flist.abrf.org%2Fr%2Ftopic%2F5d6flRAxaekAadyNSGTPRL&data=02%7C01%7Cs.meyn%40vumc.org%7C949fc3ae02e3426370dd08d7cba31260%7Cef57503014244ed8b83c12c533d879ab%7C0%7C0%7C637201773558937916&sdata=wj7vhzS6Pbas5%2FJkLFeDvnpADsWLuJlq6NQa%2FYvPA9k%3D&reserved=0 Leave group <email obscured>?Subject=Unsubscribe [ WARNING : This email came from an external source. Please treat this message with additional caution.]